Tel.: +7 (495) 925-6561 / 62 | Fax: +7 (499) 248-0734 | E-mail:
PDF, ZIP
27.03.2012 With patent running out, AZ loses bid to block Seroquel copies
27.03.2012 Valeant nabs Russia's Natur Produkt for $175M-plus
27.03.2012 J&J's Risperdal cases head to court in Texas, Arkansas
23.03.2012 GSK to build new U.K. site, create up to 1,000 jobs
23.03.2012 Study: No reason teens can't buy emergency contraception OTC
23.03.2012 Health Canada tells hospitals to quarantine morphine from Sandoz
23.03.2012 Is Watson poised to grab Actavis?
16.03.2012 Bayer eyes 16% pharma growth on new meds
16.03.2012 GSK offloads consumer brands to Omega, delays Alli sale
28.02.2012 Would you throw away a week in the Bahamas?
28.02.2012 India no longer polio endemic says WHO
28.02.2012 Antipsychotics death risk charted in dementia patients
28.02.2012 Unlimited human eggs 'potential' for fertility treatment
15.02.2012 NACDS, California pharmacy groups urge CMS to block proposed state plan amendment
15.02.2012 P&G expands Crest 3D White portfolio
15.02.2012 Report: FTC to rule on Express Scripts, Medco merger within 30 days
15.02.2012 Valeant to acquire Eyetech
15.02.2012 Columbia Labs transfers NDA for reproductive drug to Watson
10.02.2012 AZ’s China R&D strategy calls for outsourcing
10.02.2012 Hints of a heroin vaccine from Mexico
Back
16.12.2011 Post-Release of 18th International Specialized Trade Fair APTEKA 2011
01.12.2011 PRESS RELEASE of the 18th International Specialized Trade Fair APTEKA 2011
01.12.2011 The list of exhibitors of Apteka 2011
01.12.2011 The final program of the International Medical and Pharmaceutical Business Forum is published
All news
Next >>>